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558 Letters to the Editorhallucinations is unusual for intoxication with atropine or
scopolamine, but could be explained by delayed digestion
of non-ground Jimson weed seeds. Postprandial ‘inability to
vomit’, followed by unconsciousness and auditory hallucina-
tions, as reported by this patient, clearly is consistent with
tropane alkaloid poisoning, and, together with laboratory
results (50 seeds D. stramonium/kg of grain), confirm con-
tamination by Jimson weed to be the cause of this event.
Foodborne disease outbreaks are recognized by the occur-
rence of illness within a variable but usually short time period
after a meal, among individuals who have consumed foods in
common. Prompt and thorough laboratory evaluation of cases
and implicated foods is essential. Food poisoning due to
Jimson weed may mimic B. cereus food intoxication and
therefore should be considered as a differential diagnosis.
The increasing propagation of organic farming with the
refusal to use pesticides may increase the occurrence of
food poisoning due to Jimson weed in the future.
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Urinary tract infections (UTIs) having pathogenic Escherichia
coli as the etiologic agent, remain a common and troublesome
health problem in many countries, resulting in considerable
morbidity andcosts.1Non-complicated infections, particularly
in women, account for the highest number of UTIs. Women
diagnosed with acute uncomplicated cystitis are usually trea-
ted as outpatients; the microbiologic characteristics of this
infection are highly predictable even in otherwise healthy
subjects. Physicians have therefore been advised that empiri-
cal antimicrobial treatment not requiring culture is appropri-
ate in such cases. This empiric therapy has been widely
employed and fewer UTI germs are now routinely cultured.
However, increasing antibiotic resistance of uropathogens
causing both community- and nosocomially-acquired UTIs
has been clearly demonstrated.2,3
Different levels of population treatment exist within the
health system in Brazil. ‘Primary care’ takes place at the
municipal health center (essentially a doctor’s office), ‘sec-
ondary care’ is performed at the municipal hospitals, and the
‘tertiary care’ system essentially takes place at university
teaching hospitals. Within these systems, updated knowl-edge of causal bacteria and their susceptibility patterns is
important for the proper selection and use of antibiotics, as
well as for an appropriate prescribing policy. We conducted a
study to verify the antimicrobial resistance of E. coli among
UTI isolates from the ‘primary care’ and ‘tertiary care’
systems in Ribeira˜o Preto, Sa˜o Paulo, Brazil.
The antimicrobial resistance profile infection data
obtained from the Clinical Hospital of the School of Medicine
of Ribeira˜o Preto (HCFMRP), a university teaching hospital,
and from municipal health centers, concerning E. coli iso-
lated from UTI patients, were monitored and analyzed.
Isolates were collected between July 2000 and July 2003.
A total of 67 strains of E. coli isolated from HCFMRP and 78
strains from themunicipal health centers were analyzed. The
isolation and identification of E. coli strains was performed by
minimal standard bacteriological tests using conventional
biochemical markers;4 one isolate per patient was evaluated.
Antimicrobial susceptibility was determined by the Kirby—
Bauer disk diffusion method following the definitions of the
National Committee for Clinical Laboratory Standards
(NCCLS) for agar diffusion tests5 using antibiotic-containing
disks (CEFAR Diagnostica Ltd, Sa˜o Paulo, Brazil). Quality
control was performed using E. coli ATCC 25922.
Tests on the susceptibility of E. coli isolates to antimi-
crobial drugs showed that the highest rates of resistance
were found among those from the hospital patients, with
resistances at least twice as high as those of the isolates
doi:10.1016/j.ijid.2006.10.007
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Table 1 Antimicrobial resistance of Escherichia coli isolates
from a tertiary-care teaching hospital and municipal health
centers in Brazil
Antibiotic Resistance (% of isolates)
Hospital
(67 strains)
Municipal health
centers (78 strains)
Ampicillin 65.0 37.0
Cephalothin 58.0 8.0
Cefoxitin 24.0 0.0
Cefuroxime 18.0 1.0
Ceftriaxone 6.0 1.0
Gentamicin 13.0 0.0
Tobramycin 22.0 3.0
Tetracycline 73.0 31.0
Norfloxacin 31.0 12.0
Nitrofurantoin 18.0 5.0
Trimethoprim/
sulfamethoxazole
58.0 29.0from the municipal health centers. Resistance was highest
to tetracycline (73.0%), ampicillin (65.0%), cephalothin
(58.0%) and trimethoprim/sulfamethoxazole (TMP/SMX,
58.0%) (Table 1). In spite of the high potency of fluoroqui-
nolones against E. coli isolates, a relatively high resistance
to norfloxacin was observed: 31.0% in the hospital and 12.0%
in the municipal unit patients (Table 1).
UTIs are one of the most common infectious diseases
diagnosed in outpatients as well as in hospitalized patients.
Susceptibility to antimicrobial agents among hospitalized
patients3,6 and among outpatients7,8 has been shown. The
rates we report in the present study for patients from the
hospital agree with those reported by Gales et al.3 in anti-
microbial surveillance studies in Latin American hospitals
including some from Brazil, but are higher than those
reported for Canadian6 hospitalized patients.
Many factors may have contributed to such high rates of
resistance including misuse of antibiotics by healthcare pro-
fessionals or non-skilled practitioners, misuse of antibiotics
by the general public (antibiotics can be purchased in Brazil
without a prescription), and inadequate surveillance due to a
lack of information arising from routine antimicrobial sus-
ceptibility testing. The resistance rates to isolates from the
municipal health centers reported in the present study are
higher7 or lower8 than those reported in other studies; how-
ever, in all of these other studies, the reported rate of
fluoroquinolone resistance was lower than that observed in
the present study.
In agreement with the high rates reported in the present
study, a significant increase in resistance of uropathogenic
strains to TMP/SMX, ampicillin and cephalothin has been
found worldwide;9 therefore, these agents are in general
not recommended for first line empirical treatment of UTIs.
Therapies other than those described above may have to be
taken into consideration in Brazil, possibly using older agents
like gentamicin and nitrofurantoin that still show high effi-
cacy against UTI pathogens.
In conclusion, E. coli isolated from hospital or municipal
health center UTIs are to a significant extent resistant to
many antimicrobial agents. The use of TMP/SMX, ampicillinand cephalothin against uropathogens has to be re-exam-
ined. Also, the high resistance rates to fluoroquinolones in
Brazil gives rise to concern. Regular monitoring of antimi-
crobial drug resistance appears necessary to improve our
guidelines for empirical antibiotic therapy.
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